Renhe Pharmacy Co Ltd Total Assets
Renhe Pharmacy Co Ltd total assets. Based on the latest financial reports, Renhe Pharmacy Co Ltd (000650) holds total assets worth CN¥7.93 Billion CNY (≈ $1.16 Billion USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see market value of Renhe Pharmacy Co Ltd for the company's overall valuation and market capitalisation.
Total Assets of Renhe Pharmacy Co Ltd (1993–2025)
Total assets of Renhe Pharmacy Co Ltd from 1993 to 2025. This chart illustrates how Renhe Pharmacy Co Ltd's total assets have evolved over time, based on quarterly financial data. See today's stock price for Renhe Pharmacy Co Ltd for real-time trading data and today's change.
Renhe Pharmacy Co Ltd - Asset Composition Analysis
Renhe Pharmacy Co Ltd Total Assets Breakdown (December 2025)
Renhe Pharmacy Co Ltd total assets breakdown as of December 2025. Renhe Pharmacy Co Ltd's total assets of CN¥7.93 Billion consist of 63.9% current assets and 36.1% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 35.9% |
| Accounts Receivable | CN¥206.58 Million | 2.7% |
| Inventory | CN¥531.11 Million | 6.9% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥301.06 Million | 3.9% |
| Goodwill | CN¥390.89 Million | 5.1% |
Asset Composition Trend (1993–2025)
This chart illustrates how Renhe Pharmacy Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Renhe Pharmacy Co Ltd (000650) liquidity to equity ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Renhe Pharmacy Co Ltd's current assets represent 63.9% of total assets in 2025, an increase from 26.0% in 1993.
- Cash Position: Cash and equivalents constituted 35.9% of total assets in 2025, up from 2.3% in 1993.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 8.0% of total assets, an increase from 0.0% in 1993.
- Asset Diversification: The largest asset category is inventory at 6.9% of total assets.
Renhe Pharmacy Co Ltd Competitors by Total Assets
Key competitors of Renhe Pharmacy Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Jiangsu Hengrui Medicine Co Ltd
SHG:600276
|
China | CN¥68.33 Billion |
|
Sandoz Group AG
SW:SDZ
|
Switzerland | CHF22.86 Billion |
|
H Lundbeck A/S
CO:HLUN-B
|
Denmark | Dkr54.01 Billion |
|
Changchun High & New Technology Industries Group Inc
SHE:000661
|
China | CN¥30.77 Billion |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566
|
China | CN¥17.01 Billion |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518
|
China | CN¥13.68 Billion |
|
Viyash Scientific Limited
NSE:SEQUENT
|
India | Rs17.26 Billion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥5.11 Billion |
Renhe Pharmacy Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 6.58 | 8.25 | 5.05 |
| Quick Ratio | 6.08 | 7.59 | 4.34 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥4.37 Billion | CN¥4.39 Billion | CN¥2.93 Billion |
Renhe Pharmacy Co Ltd - Advanced Valuation Insights
This section examines the relationship between Renhe Pharmacy Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.24 |
| Latest Market Cap to Assets Ratio | 0.14 |
| Asset Growth Rate (YoY) | 3.4% |
| Total Assets | CN¥7.74 Billion |
| Market Capitalization | $1.06 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Renhe Pharmacy Co Ltd's assets below their book value (0.14x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Renhe Pharmacy Co Ltd's assets grew by 3.4% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Renhe Pharmacy Co Ltd (1993–2025)
The table below shows the annual total assets of Renhe Pharmacy Co Ltd from 1993 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥7.74 Billion ≈ $1.13 Billion |
+3.38% |
| 2024-12-31 | CN¥7.48 Billion ≈ $1.09 Billion |
+0.51% |
| 2023-12-31 | CN¥7.44 Billion ≈ $1.09 Billion |
-2.45% |
| 2022-12-31 | CN¥7.63 Billion ≈ $1.12 Billion |
+10.48% |
| 2021-12-31 | CN¥6.91 Billion ≈ $1.01 Billion |
+9.56% |
| 2020-12-31 | CN¥6.31 Billion ≈ $922.63 Million |
+26.50% |
| 2019-12-31 | CN¥4.98 Billion ≈ $729.38 Million |
+7.97% |
| 2018-12-31 | CN¥4.62 Billion ≈ $675.56 Million |
+10.78% |
| 2017-12-31 | CN¥4.17 Billion ≈ $609.82 Million |
+7.83% |
| 2016-12-31 | CN¥3.86 Billion ≈ $565.56 Million |
+22.45% |
| 2015-12-31 | CN¥3.16 Billion ≈ $461.86 Million |
+21.53% |
| 2014-12-31 | CN¥2.60 Billion ≈ $380.04 Million |
+11.53% |
| 2013-12-31 | CN¥2.33 Billion ≈ $340.76 Million |
+11.16% |
| 2012-12-31 | CN¥2.09 Billion ≈ $306.54 Million |
+30.70% |
| 2011-12-31 | CN¥1.60 Billion ≈ $234.54 Million |
+8.43% |
| 2010-12-31 | CN¥1.48 Billion ≈ $216.30 Million |
+39.34% |
| 2009-12-31 | CN¥1.06 Billion ≈ $155.24 Million |
+142.32% |
| 2008-12-31 | CN¥437.80 Million ≈ $64.06 Million |
+41.92% |
| 2007-12-31 | CN¥308.48 Million ≈ $45.14 Million |
+13.53% |
| 2006-12-31 | CN¥271.72 Million ≈ $39.76 Million |
-40.41% |
| 2005-12-31 | CN¥456.00 Million ≈ $66.73 Million |
-24.09% |
| 2004-12-31 | CN¥600.73 Million ≈ $87.91 Million |
-11.58% |
| 2003-12-31 | CN¥679.38 Million ≈ $99.41 Million |
-10.57% |
| 2002-12-31 | CN¥759.66 Million ≈ $111.16 Million |
+6.70% |
| 2001-12-31 | CN¥711.94 Million ≈ $104.18 Million |
+9.26% |
| 2000-12-31 | CN¥651.61 Million ≈ $95.35 Million |
+36.83% |
| 1999-12-31 | CN¥476.21 Million ≈ $69.69 Million |
+32.26% |
| 1998-12-31 | CN¥360.06 Million ≈ $52.69 Million |
+29.43% |
| 1997-12-31 | CN¥278.20 Million ≈ $40.71 Million |
+3.14% |
| 1996-12-31 | CN¥269.74 Million ≈ $39.47 Million |
+57.91% |
| 1995-12-31 | CN¥170.81 Million ≈ $25.00 Million |
-1.11% |
| 1994-12-31 | CN¥172.73 Million ≈ $25.28 Million |
+33.22% |
| 1993-12-31 | CN¥129.66 Million ≈ $18.97 Million |
-- |
About Renhe Pharmacy Co Ltd
Renhe Pharmacy Co.,Ltd produces and sells pharmaceutical products. It offers Chinese and western medicines and raw materials; and health-related products, including oral solid preparations and liquid preparations, large-volume and small-volume injections, external lotions, liniments, suppositories, ointments, and other dosage forms of drugs and health-related products. The company was founded in … Read more